Lack of confidence in CCDSS demands careful assessment on the impact of CCDSS on medication safety; excessive numbers of alerts and high signal to noise ratios causing alert burden calls for further modifications to the systems; and lack of suggested actions within alerts that prescribers could directly accept (ie, an alternative order) requires further improvements to the existing CCDSS.
This CPOE system for prescribing medication generates intrusive drug safety alerts for DDIs, overdoses, and therapeutic duplications based on information held in the G Standard database.
In conjunction with pharmacy departments, they can ensure that guidelines are evidence based and respond to national safety alerts that are medication related, such as the MHRA guidance for codeine use in children.
Although computerized drug-drug interaction alert systems that require password overrides appear useful for promoting medication safety, having to enter passwords to override alerts may represent an excessive burden for the prescribing physician.
The ADM uses broad clinical decision support to incorporate many criteria into medication dosing such as weight, age, indication, and safety alerts that are built into clinical content.
While prescribers' response to the alerts also contribute to overall medication safety, their response may depend on multiple other factors (ie, personal choice, prescribers' acceptance/confidence in CCDSS, etc), which can be separately explored with further research.
Regardless of the appropriate categorization of this factor, or why the clinicians are behind schedule, there was a strong correlation between those physicians who reported being behind schedule and several key practices that our organization is trying to promote, including accepting safety alerts, looking up information on specific medications, and using on-line reference information.
This study was embarked upon to assess the impact of the newly implemented automated PHS text alert system on clinician prescribing behavior, specifically warfarin dosing, monitoring frequency, and medication safety (incidence of severe hemorrhage and thromboembolic events), as well as to identify potential opportunities for PHS alert system improvement.
A platform of data investigations utilizing the 'Wisdom of the Crowd' focusing on biosurveillances aspects as follows: 1. Pharmacovigilance brand monitoring and safety alerts: Crowd trial provides a dashboard of parameters on medications, their side effect profile, interactions and drug's comparative advantage.
